GGrantIndex
← Leaderboards

James Warren Murrough

Va Connecticut Healthcare System

$11,441,785
Attributed
$14,675,471
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY201125
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,460,577 · 11
VA$0 · 2

By mechanism

U19$8,753,457 · 3
R01$5,933,184 · 3
R33$2,380,565 · 1
R61$1,638,417 · 1
UG3$1,377,361 · 1
K23$911,468 · 1

Most similar at Va Connecticut Healthcare System

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseMental DepressionFunctional DisorderBrainMajor Depressive DisorderRegulationPeripheralIn VivoDoseDepressive SymptomsBehavioralAnxietyFunctional Magnetic Resonance ImagingRandomizedAnimalsStressBehaviorPhenotypeStress Related DisorderResearch Project GrantsDesignFutureLaboratoriesPrefrontal Cortex

Grant awards (40)

Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI$765,927
R01 · FY2025 · MH · contact PI
Integrating Immune Dysregulation and Reward Circuitry in Veterans with Mood Disorders and Suicide"$0
I01 · FY2025 · VA
Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression$1,377,361
UG3 · FY2024 · MH
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$1,161,013
U19 · FY2024 · AT · contact PI
Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI$765,927
R01 · FY2024 · MH · contact PI
Clinical Pharmacology and Target Validation of BDPP for Stress-Related Disorders$395,598
U19 · FY2024 · AT · contact PI
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$1,188,602
U19 · FY2023 · AT
Developing Neuronal KCNQ Channel Modulators for Mood Disorders$776,711
R33 · FY2023 · MH · contact PI
Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI$768,462
R01 · FY2023 · MH · contact PI
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$520,443
R01 · FY2023 · MH · contact PI
Clinical Pharmacology and Target Validation of BDPP for Stress-Related Disorders$394,413
U19 · FY2023 · AT · contact PI
Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine$338,000
R01 · FY2023 · DK
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$97,018
R01 · FY2023 · MH · contact PI
VA Aripiprazole vs. Esketamine for Treatment of Depression VAST-D II$0
I01 · FY2023 · VA
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$1,192,792
U19 · FY2022 · AT
Developing Neuronal KCNQ Channel Modulators for Mood Disorders$811,339
R33 · FY2022 · MH · contact PI
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$579,441
R01 · FY2022 · MH · contact PI
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$422,500
U19 · FY2022 · AT
Clinical Pharmacology and Target Validation of BDPP for Stress-Related Disorders$382,830
U19 · FY2022 · AT · contact PI
Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine$338,000
R01 · FY2022 · DK
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$1,196,449
U19 · FY2021 · AT
Developing Neuronal KCNQ Channel Modulators for Mood Disorders$792,515
R33 · FY2021 · MH · contact PI
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$579,441
R01 · FY2021 · MH · contact PI
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$423,750
U19 · FY2021 · AT
Clinical Pharmacology and Target Validation of BDPP for Stress-Related Disorders$395,208
U19 · FY2021 · AT · contact PI
VA Aripiprazole vs. Esketamine for Treatment of Depression VAST-D II$0
I01 · FY2021 · VA
Influence of Dietary Botanical Supplements on Biological and Behavioral Resilience$1,200,000
U19 · FY2020 · AT
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$609,936
R01 · FY2020 · MH · contact PI
Clinical Pharmacology and Target Validation of BDPP for Stress-Related Disorders$400,302
U19 · FY2020 · AT · contact PI
Transdiagnostic Multimodal 7 Tesla MRI of the Locus Coeruleus in Human Pathological Anxiety$570,589
R01 · FY2019 · MH · contact PI
Developing Neuronal KCNQ Channel Modulators for Mood Disorders$802,607
R61 · FY2018 · MH · contact PI
Developing Neuronal KCNQ Channel Modulators for Mood Disorders$835,810
R61 · FY2017 · MH · contact PI
Inflammatory and neurocircuit mechanisms of anhedonia in human depression$254,250
R21 · FY2017 · MH · contact PI
Inflammatory and neurocircuit mechanisms of anhedonia in human depression$211,875
R21 · FY2016 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$176,518
K23 · FY2015 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$176,518
K23 · FY2014 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$29,592
K23 · FY2014 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$176,517
K23 · FY2013 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$176,357
K23 · FY2012 · MH · contact PI
Functional MRI Studies of Emotion in Depression and Rapid Antidepressant Response$175,966
K23 · FY2011 · MH · contact PI